NCT05808205View on ClinicalTrials.gov

An Open, Non-comparative, Single-centre Post Marketing Clinical Followup (PMCF) Investigation to Evaluate Performance and Safety of the ALIAXIN Fillers Used as Intended

RecruitingOBSERVATIONAL

Enrollment

350

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions

Esthetics

Interventions

DEVICE

• ALIAXIN EV: Essential Volume • ALIAXIN FL: Lips • ALIAXIN SR: Shape & Restore • ALIAXIN GP: Global Performance • ALIAXIN LV: Lips Volume

"According the investigator judgment and IP' Instruction For Use (IFU), each subject can be treated in one or more of following face area:~* Temporal / frontal area~* Orbital / Malar area~* Perioral area~* Lips."

Trial Locations (1)

Unknown

RECRUITING

Clinica Capitanio - Istituto Auxologico Italiano IRCCS Milano, Milan

All Listed Sponsors

lead

Rose Pharma SA

INDUSTRY